Boehringer Ingelheim: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Boehringer Ingelheim}} | |||
[[File:Boehringer_Ingelheim_Logo_RGB_Dark_Green.svg|Boehringer Ingelheim Logo|thumb|right]] | |||
'''Boehringer Ingelheim''' is a global pharmaceutical company headquartered in Ingelheim am Rhein, Germany. Founded in 1885 by [[Albert Boehringer]], the company has grown to become one of the world's leading research-driven pharmaceutical enterprises. | |||
Boehringer Ingelheim' | |||
== | ==History== | ||
Boehringer Ingelheim | [[File:AlbertB.jpg|Albert Boehringer, founder of Boehringer Ingelheim|thumb|left]] | ||
The company was established by Albert Boehringer in 1885 in the small town of Ingelheim am Rhein. Initially, the company focused on the production of tartaric acid salts, which were used in the food industry. In 1893, Boehringer discovered that lactic acid could be produced in large quantities through bacterial fermentation, marking a significant milestone in the company's history. | |||
In 1917, Boehringer Ingelheim patented its first pharmaceutical product, a baking powder called Boeson. This marked the company's entry into the pharmaceutical industry. | |||
Boehringer Ingelheim | |||
== | [[File:Poster_for_Boeson_baking_powder,_the_first_patented_Boehringer_Ingelheim_product.jpg|Poster for Boeson baking powder, the first patented Boehringer Ingelheim product|thumb|right]] | ||
==Research and Development== | |||
Boehringer Ingelheim is renowned for its commitment to research and development (R&D). The company invests a significant portion of its revenue into R&D, focusing on areas such as respiratory diseases, cardiometabolic diseases, oncology, and diseases of the central nervous system. | |||
==Global Presence== | |||
Boehringer Ingelheim operates globally, with a presence in over 100 countries. The company employs more than 50,000 people worldwide and has a strong commitment to improving human and animal health. | |||
==Products== | |||
The company's product portfolio includes prescription medicines, consumer health care products, and animal health products. Some of its well-known products include [[Spiriva]], [[Pradaxa]], and [[NexGard]]. | |||
==Corporate Social Responsibility== | |||
Boehringer Ingelheim is committed to corporate social responsibility, focusing on sustainable development, environmental protection, and social engagement. The company supports various initiatives aimed at improving health care access and education in underserved communities. | |||
==Headquarters== | |||
[[File:Ingelheim_site,_of_Boehringer_Ingelheim.jpg|Ingelheim site of Boehringer Ingelheim|thumb|left]] | |||
The company's headquarters are located in Ingelheim am Rhein, Germany. The site includes state-of-the-art research facilities and serves as the central hub for the company's global operations. | |||
==Related pages== | |||
* [[Pharmaceutical industry]] | * [[Pharmaceutical industry]] | ||
* [[Albert Boehringer]] | |||
* [[Research and development]] | * [[Research and development]] | ||
[[Category:Pharmaceutical companies]] | [[Category:Pharmaceutical companies of Germany]] | ||
[[Category:Companies established in 1885]] | [[Category:Companies established in 1885]] | ||
[[Category: | [[Category:Family-owned companies]] | ||
Latest revision as of 11:26, 23 March 2025
Boehringer Ingelheim is a global pharmaceutical company headquartered in Ingelheim am Rhein, Germany. Founded in 1885 by Albert Boehringer, the company has grown to become one of the world's leading research-driven pharmaceutical enterprises.
History[edit]
The company was established by Albert Boehringer in 1885 in the small town of Ingelheim am Rhein. Initially, the company focused on the production of tartaric acid salts, which were used in the food industry. In 1893, Boehringer discovered that lactic acid could be produced in large quantities through bacterial fermentation, marking a significant milestone in the company's history.
In 1917, Boehringer Ingelheim patented its first pharmaceutical product, a baking powder called Boeson. This marked the company's entry into the pharmaceutical industry.
Research and Development[edit]
Boehringer Ingelheim is renowned for its commitment to research and development (R&D). The company invests a significant portion of its revenue into R&D, focusing on areas such as respiratory diseases, cardiometabolic diseases, oncology, and diseases of the central nervous system.
Global Presence[edit]
Boehringer Ingelheim operates globally, with a presence in over 100 countries. The company employs more than 50,000 people worldwide and has a strong commitment to improving human and animal health.
Products[edit]
The company's product portfolio includes prescription medicines, consumer health care products, and animal health products. Some of its well-known products include Spiriva, Pradaxa, and NexGard.
Corporate Social Responsibility[edit]
Boehringer Ingelheim is committed to corporate social responsibility, focusing on sustainable development, environmental protection, and social engagement. The company supports various initiatives aimed at improving health care access and education in underserved communities.
Headquarters[edit]
The company's headquarters are located in Ingelheim am Rhein, Germany. The site includes state-of-the-art research facilities and serves as the central hub for the company's global operations.
